Isolation of biologically active and morphologically intact exosomes from plasma of patients with cancer

Journal of Extracellular Vesicles

Volumn 5, Issue 1, 2016, Pages

  Hong, Chang Sook ^a   Funk, Sonja ^a,b   Muller, Laurent ^a,c   Boyiadzis, Michael ^a   Whiteside, Theresa L ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

exosome functions; exosome isolation; exosome morphology; human cancer; human plasma; mini size exclusion column chromatography

Indexed keywords

NATURAL KILLER CELL RECEPTOR NKG2D; PHOSPHATE BUFFERED SALINE;

ACUTE MYELOID LEUKEMIA; ARTICLE; CELL COUNT; CELL ISOLATION; CELL STRUCTURE; CENTRIFUGATION; CONTROLLED STUDY; ELUTION; EXOSOME; FRACTIONATION; GENE INACTIVATION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; INCUBATION TIME; LYMPHOCYTE PROLIFERATION; MOLECULAR BIOLOGY; NATURAL KILLER CELL; PARTICLE SIZE; PROTEIN CONTENT; PROTEIN EXPRESSION; SIZE EXCLUSION CHROMATOGRAPHY; T LYMPHOCYTE; TRANSMISSION ELECTRON MICROSCOPY; ULTRAFILTRATION; WESTERN BLOTTING;

EID: 85006075858     PISSN: None     EISSN: 20013078     Source Type: Journal    
DOI: 10.3402/jev.v5.29289     Document Type: Article

References (38)

1. Cocucci E, Meldolesi J. Ectosomes and exosomes: shedding the confusion between extracellular vesicles. Trends Cell Biol. 2015; 25: 364–72. doi: http://dx.doi.org/10.1016/j.tcb.2015.01.004.
2. Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 2013; 200: 373–83. doi: http://dx.doi.org/10.1083/jcb.201211138.
3. Graner MW, Alzate O, Dechkovskaia AM, Keene JD, Sampson JH, Mitchell DA, etal. Proteomic and immunologic analyses of brain tumor exosomes. FASEB J. 2009; 23: 1541–57. doi: http://dx.doi.org/10.1096/fj.08-122184.
4. Brinton LT, Sloane HS, Kester M, Kelly KA. Formation and role of exosomes in cancer. Cell Mol Life Sci. 2015; 72: 659–71. doi: http://dx.doi.org/10.1007/s00018-014-1764-3.
5. Peinado H, Aleckovic M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, etal. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med. 2012; 18: 883–91. doi: http://dx.doi.org/10.1038/nm.2753.
6. Szczepanski MJ, Szajnik M, Welsh A, Whiteside TL, Boyiadzis M. Blast-derived microvesicles in sera from patients with acute myeloid leukemia suppress natural killer cell function via membrane-associated transforming growth factor-beta1. Haematologica. 2011; 96: 1302–9. doi: http://dx.doi.org/10.3324/haematol.2010.039743.
7. De Toro J, Herschlik L, Waldner C, Mongini C. Emerging roles of exosomes in normal and pathological conditions: new insights for diagnosis and therapeutic applications. Front Immunol. 2015; 6: 203. doi: http://dx.doi.org/10.3389/fimmu.2015.00203.
8. Thery C, Amigorena S, Raposo G, Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol. 2006. Chapter 3:Unit 3.22. doi: http://dx.doi.org/10.1002/0471143030.cb0322s30.
9. Montecalvo A, Larregina AT, Morelli AE. Methods of purification of CTL-derived exosomes. Methods Mol Biol. 2014; 1186: 87–102. doi: http://dx.doi.org/10.1007/978-1-4939-1158-5_7.
10. Taylor DD, Shah S. Methods of isolating extracellular vesicles impact down-stream analyses of their cargoes. Methods. 2015; 87: 3–10. doi: http://dx.doi.org/10.1016/j.ymeth.2015.02.019.
11. Taylor DD, Chou IN, Black PH. Isolation of plasma membrane fragments from cultured murine melanoma cells. Biochem Biophys Res Commun. 1983; 113: 470–6.
12. Hong CS, Muller L, Boyiadzis M, Whiteside TL. Isolation and characterization of CD34+ blast-derived exosomes in acute myeloid leukemia. PLoS One. 2014; 9: e103310. doi: http://dx.doi.org/10.1371/journal.pone.0103310.
13. Saze Z, Schuler PJ, Hong CS, Cheng D, Jackson EK, Whiteside TL. Adenosine production by human B cells and B cell-mediated suppression of activated T cells. Blood. 2013; 122: 9–18. doi: http://dx.doi.org/10.1182/blood-2013-02-482406.
14. Muller L, Hong CS, Stolz DB, Watkins SC, Whiteside TL. Isolation of biologically-active exosomes from human plasma. J Immunol Methods. 2014; 411: 55–65. doi: http://dx.doi.org/10.1016/j.jim.2014.06.007.
15. Strauss L, Bergmann C, Whiteside TL. Human circulating CD4+CD25highFoxp3+ regulatory T cells kill autologous CD8+ but not CD4+ responder cells by Fas-mediated apoptosis. J Immunol. 2009; 182: 1469–80.
16. Wieckowski EU, Visus C, Szajnik M, Szczepanski MJ, Storkus WJ, Whiteside TL. Tumor-derived microvesicles promote regulatory T cell expansion and induce apoptosis in tumor-reactive activated CD8+ T lymphocytes. J Immunol. 2009; 183: 3720–30. doi: http://dx.doi.org/10.4049/jimmunol.0900970.
17. Hong CS, Muller L, Whiteside TL, Boyiadzis M. Plasma exosomes as markers of therapeutic response in patients with acute myeloid leukemia. Front Immunol. 2014; 5: 160. doi: http://dx.doi.org/10.3389/fimmu.2014.00160.
18. Kim JW, Wieckowski E, Taylor DD, Reichert TE, Watkins S, Whiteside TL. Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes. Clin Cancer Res. 2005; 11: 1010–20.
19. Whiteside TL. Immune modulation of T-cell and NK (natural killer) cell activities by TEXs (tumour-derived exosomes). Biochem Soc Trans. 2013; 41: 245–51. doi: http://dx.doi.org/10.1042/BST20120265.
20. Taylor DD, Zacharias W, Gercel-Taylor C. Exosome isolation for proteomic analyses and RNA profiling. Methods Mol Biol. 2011; 728: 235–46. doi: http://dx.doi.org/10.1007/978-1-61779-068-3_15.
21. Chen C, Skog J, Hsu CH, Lessard RT, Balaj L, Wurdinger T, etal. Microfluidic isolation and transcriptome analysis of serum microvesicles. Lab Chip. 2010; 10: 505–11. doi: http://dx.doi.org/10.1039/b916199f.
22. Tauro BJ, Greening DW, Mathias RA, Ji H, Mathivanan S, Scott AM, etal. Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes. Methods. 2012; 56: 293–304. doi: http://dx.doi.org/10.1016/j.ymeth.2012.01.002.
23. Kowal J, Tkach M, Thery C. Biogenesis and secretion of exosomes. Curr Opin Cell Biol. 2014; 29: 116–25. doi: http://dx.doi.org/10.1016/j.ceb.2014.05.004.
24. Martins VR, Dias MS, Hainaut P. Tumor-cell-derived microvesicles as carriers of molecular information in cancer. Curr Opin Oncol. 2013; 25: 66–75. doi: http://dx.doi.org/10.1097/CCO.0b013e32835b7c81.
25. Muller L, Muller-Haegele S, Mitsuhashi M, Gooding W, Okada H, Whiteside TL. Exosomes isolated from plasma of glioma patients enrolled in a vaccination trial reflect antitumor immune activity and might predict survival. Oncoimmunology. 2015; 4: e1008347. doi: http://dx.doi.org/10.1080/2162402X.2015.1008347.
26. Khan S, Aspe JR, Asumen MG, Almaguel F, Odumosu O, Acevedo-Martinez S, etal. Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential. Br J Cancer. 2009; 100: 1073–86. doi: http://dx.doi.org/10.1038/sj.bjc.6604978.
27. Welton JL, Webber JP, Botos LA, Jones M, Clayton A. Ready-made chromatography columns for extracellular vesicle isolation from plasma. J Extracell Vesicles. 2015; 4: 27269. doi: http://dx.doi.org/10.3402/jev.v4.27269.
28. Boing AN, van der Pol E, Grootemaat AE, Coumans FA, Sturk A, Nieuwland R. Single-step isolation of extracellular vesicles by size-exclusion chromatography. J Extracell Vesicles. 2014; 3: 23430. doi: http://dx.doi.org/10.3402/jev.v3.23430.
29. de Menezes-Neto A, Saez MJ, Lozano-Ramos I, Segui-Barber J, Martin-Jaular L, Ullate JM, etal. Size-exclusion chromatography as a stand-alone methodology identifies novel markers in mass spectrometry analyses of plasma-derived vesicles from healthy individuals. J Extracell Vesicles. 2015; 4: 27378. doi: http://dx.doi.org/10.3402/jev.v4.27378.
30. Bergmann C, Strauss L, Wieckowski E, Czystowska M, Albers A, Wang Y, etal. Tumor-derived microvesicles in sera of patients with head and neck cancer and their role in tumor progression. Head Neck. 2009; 31: 371–80. doi: http://dx.doi.org/10.1002/hed.20968.
31. Balaj L, Atai NA, Chen W, Mu D, Tannous BA, Breakefield XO, etal. Heparin affinity purification of extracellular vesicles. Sci Rep. 2015; 5: 10266. doi: http://dx.doi.org/10.1038/srep10266.
32. Andreola G, Rivoltini L, Castelli C, Huber V, Perego P, Deho P, etal. Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles. J Exp Med. 2002; 195: 1303–16.
33. Webber J, Steadman R, Mason MD, Tabi Z, Clayton A. Cancer exosomes trigger fibroblast to myofibroblast differentiation. Cancer Res. 2010; 70: 9621–30. doi: http://dx.doi.org/10.1158/0008-5472.CAN-10-1722.
34. Szajnik M, Czystowska M, Szczepanski MJ, Mandapathil M, Whiteside TL. Tumor-derived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (Treg). PLoS One. 2010; 5: e11469. doi: http://dx.doi.org/10.1371/journal.pone.0011469.
35. Mrizak D, Martin N, Barjon C, Jimenez-Pailhes AS, Mustapha R, Niki T, etal. Effect of nasopharyngeal carcinoma-derived exosomes on human regulatory T cells. J Natl Cancer Inst. 2015; 107: 363. doi: http://dx.doi.org/10.1093/jnci/dju363.
36. Whiteside TL. Immune responses to cancer: are they potential biomarkers of prognosis?. Front Oncol. 2013; 3: 107. doi: http://dx.doi.org/10.3389/fonc.2013.00107.
37. Hwang I, Ki D. Receptor-mediated T cell absorption of antigen presenting cell-derived molecules. Front Biosci (Landmark Ed). 2011; 16: 411–21.
38. Lane RE, Korbie D, Anderson W, Vaidyanathan R, Trau M. Analysis of exosome purification methods using a model liposome system and tunable-resistive pulse sensing. Sci Rep. 2015; 5: 7639. doi: http://dx.doi.org/10.1038/srep07639.